Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.

Hiroshi MatsudaTomoya UeharaHidehiko OkazawaSunao MizumuraKunihiko YokoyamaMana Yoshimuranull null

Published in: Annals of nuclear medicine (2020)

These results suggest that nuclear medicine staff must be aware of the possibility of adverse reactions from radiopharmaceuticals, despite their rarity.

Keyphrases

adverse drug
emergency department